Search results
Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study
Zacks via Yahoo Finance UK· 12 hours agoAnnovis (ANVS) surges 76% on Jul 2 after meeting the primary and secondary goals with statistical...
Placebo overcome crowd trouble to deliver unforgettable night in Southampton
Daily Echo· 6 days agoAfter a short break in which Molko threatened to leave the stage, Placebo resumed the evening’s entertainment which led to a memorable night for all the right reasons. < ...
'New era' in Alzheimer's disease treatment as second drug approved in US
Irish Examiner· 8 hours agoNew drug, which slowed cognitive and functional decline by up to 35% in trials, welcomed by...
New Research Finds Vitamin D Supplementation Could Increase Muscle Strength
Men's Health UK via Yahoo News· 1 day agoData collection: Researchers gathered data from various databases to find relevant studies. They...
Nipocalimab pivotal Phase 3 trial demonstrates sustained disease control in FcRn class for a broad...
PharmiWeb· 3 days agoPatients treated with nipocalimab plus standard of care (SOC) achieved superiority over placebo plus SOC as measured by the primary endpoint of improvement in the Myasthenia ...
‘Calm down’: Placebo forced to stop Southampton gig due to fighting in the crowd
Daily Echo· 7 days agoThe alternative rock band arrived on stage at 9pm and sent fans into a frenzy as Brian Molko and Stefan Olsdal began their 90-minute setlist. Placebo front man Brian Molko ...
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
The Daily Beast via Yahoo News UK· 1 day agoThe Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a...
Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Benzinga via Yahoo Finance UK· 12 hours agoOn Wednesday, the European Medicines Agency (EMA) approved Dupixent (dupilumab) as an add-on...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Finance UK· 13 hours agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
New Drug Approved for Early Alzheimer’s
New York Times· 1 day agoThe drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the...